Welichem Biotech Inc. ("Welichem", TSX-V: WBI) is engaged in the development and commercialization of synthesized therapeutics based on the metabolite structure of certain species of symbiotic organisms.

To achieve its goal of developing pharmaceutical drugs to treat unmet healthcare needs, Welichem performs in-house research and sponsors research that is contracted out to collaborators at major research laboratories. Our discovery and preclinical research activities comprise of purification and synthesis of the drug compounds, screening them as well as determining their mode of action and efficacy ...

Contact Information

316 - 4475 Wayburne Drive
Burnaby, BC V5G3L1

tel: 1604-432-1703
fax: 1604-432-1704


Investor Relations

e-mail: info@welichem.com


Exchange: TSX-V
Industry: Research And Development In The Life Sciences
Market Cap: N/A

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.